Antihypertensive drug therapy for mild to moderate hypertension during pregnancy

Cochrane Database of Systematic Reviews

Volumn 2018, Issue 10, 2018, Pages

  Abalos, Edgardo ^a   Duley, Lelia ^b   Steyn, D Wilhelm ^c   Gialdini, Celina ^a  

^a Centro Rosarino de Estudios Perinatales   (Argentina)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; METHYLDOPA; PLACEBO;

DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG EFFECT; ECLAMPSIA; FETUS DEATH; HUMAN; MATERNAL DEATH; MATERNAL HYPERTENSION; NEWBORN DEATH; OUTCOME ASSESSMENT; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; FEMALE; HYPERTENSION; META ANALYSIS; NEWBORN; PLACEBO EFFECT; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY;

ANTIHYPERTENSIVE AGENTS; FEMALE; FETAL DEATH; HUMANS; HYPERTENSION; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, SMALL FOR GESTATIONAL AGE; MATERNAL DEATH; PLACEBO EFFECT; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROTEINURIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85054148996     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD002252.pub4     Document Type: Review

References (307)

1. Voto L, Lapidus A, Neira J, Margulies M. Atenolol vs alpha methyldopa in the treatment of hypertension in pregnancy. 5th International Congress for the International Society for the study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, UK. 1986:138. 3034925
2. Voto LS, Lapidus AM, Neira J, Margulies M. Treatment of hypertension during pregnancy: atenolol versus alpha-methyldopa [Tratamiento de la hipertensión en el embarazo: Atenolol versus Alfa Metildopa]. Obstetricia y Ginecología Latino-Americanas 1985;43(9-10):335-41. 3034926
3. Voto LS, Zin C, Neira J, Lapidus AM, Margulies M. Ketanserin versus alpha methyldopa in the treatment of hypertension during pregnancy: a preliminary report. Journal of Cardiovascular Pharmacology 1987;10(Suppl 3):S101-S103. 3034928
4. Casavilla F, Vega HR. Prospective and randomized study on mepindolol and alpha-methydopa efficacy in arterial hypertension (AH) treatment during pregnancy. World Congress of Gynecology and Obstetrics; 1988 October 23-28; Brazil. 1988:182. 3034930
5. Livingstone I, Craswell PW, Bevan EB, Smith MT, Eadie MJ. Propranolol in pregnancy - three-year prospective study. Clinical and Experimental Hypertension 1983;2:341-50. 3034932
6. Gallery ED, Gyory AZ. Antihypertensive therapy in pregnancy [abstract]. Kidney International 1984;26(2):232. 9245995
7. Gallery ED, Hunyor SN, Saunders DM, Gyory AZ. A randomized trial of oxyprenolol and a-methyl dopa in therapy of hypertension in pregnancy. 1st Congress of the International Society of Hypertension in Pregnancy; 1978 September 27-29; Dublin, Ireland. 1978:88. 9245996
8. Gallery ED, Ross MR, Gyory AZ. Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. BMJ 1985;291:563-6. 9245997
9. Gallery ED, Saunders DM, Hunyor SN, Gyory AZ. Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. BMJ 1979;1:1591-4. 9245998
10. Davis G, Brown M. Re: glyceryl trinitrate (GTN) patches are unsuitable in hypertensive pregnancy. Australian Journal of Obstetrics and Gynaecology 2001; Vol. 41, issue 4:474. 3034939
11. Kahhale S, Carrara W, Barros AC, Zugaib M, Neme B. A comparative study between treated (beta-blocker pindolol) and untreated chronic hypertension. 4th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands. 1984:56. 3034941
12. Kahhale S, Zugaib M, Carrara W, Paula FJ, Sabbaga E, Neme B. Comparative study of chronic hypertensive pregnant women treated and non-treated with pindolol [Estudio comparativo de gestantes hipertensas crônicas tratadas e näo tratadas com betabloqueador pindolol]. Ginecologia e Obstetrícia Brasileiras 1985;8(2):85-9. 3034942
13. Freire S, de França LA, Rau de Almeida Callou M, Alves de Oliveira JE, Barbosa Filho J. Comparative study with pindolol and methyldopa in pregnant women with chronic hypertension [Estudo comparativo com pindolol e metildopa em gestantes com hipertensão arterial crônica]. Jornal Brasileiro de Ginecologia 1988;98(3):157-60. 3034944
14. Nascimento DJ. [Avaliaçäo do uso do verapamil em gestantes com formas näo graves de doença hipertensiva vascular crônica] Evaluation of the use of Verapamil with Non-serious Form of Chronic Vascular Hypertension Disease During Pregnancy [Doctoral thesis]. Brazil: Facultade Evangélica de Medicina do Paraná, 2000. 3034946
15. Trapani A Jr, Goncalves LF, Trapani TF, Vieira S, Pires M, Pires MM. Perinatal and hemodynamic evaluation of sildenafil citrate for preeclampsia treatment: A randomized controlled trial. Obstetrics and Gynecology 2016;128(2):253-9. 9246000
16. Plouin PF, Breart G, Llado J, Dalle M, Keller ME, Goujon H, et al. A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension. British Journal of Obstetrics and Gynaecology 1990;97:134-41. 3034948
17. Yla-Outinen A, Tuimala R. Management of pregnancy induced hypertension by using nifedipine - a prospective randomized trial. 6th International Congress of the International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada. 1988:133. 9246002
18. Plouin PF, Breart G, Maillard F, Papiernik E, Relier JP, Labetolol Methyldopa Study Group. Antihypertensive efficacy and perinatal safety of labetalol in the treatment of hypertension in pregnancy: a randomised comparison to methyldopa [Effets maternels et securite perinatale du labetalol dans le traitement des hypertensions de la grossesse. Comparaison a la methyldopa par un essai cooperatif randomise]. Archives des Maladies du Coeur 1987;80:952-5. 3034950
19. Plouin PF, Breart G, Maillard F, Papiernik E, Relier JP, the Labetolol Methyldopa Study Group. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. British Journal of Obstetrics and Gynaecology 1988;95:868-76. 3034951
20. Blazquez, Lardoux H, Leperlier E. Randomized and comparative study of methyl dopa (MD), acebutolol (ACE) and labetalol for the treatment of moderate hypertension during pregnancy (HDP). 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada. 1988:100. 9246004
21. Lardoux H, Blazquez G, Leperlier E, Gerard J. Randomized and comparative study of methyldopa (MD), acebutolol (ACE) and labetalol for the treatment of moderate hypertension during pregnancy (HDP) [Essai ouvert, comparatif, avec tirage au sort pour le traitement de l'HTA gravidique moderee: methyldopa, acetbutolol, labetalol]. Archives des Maladies du Coeur 1988;91:137-40. 9246005
22. Bonnin P, Mintz P, Kedra AW, Pruna A, Ciraru-Vigneron N, Savin E, et al. Effects of nifedipine and atenolol on the fetal-maternal circulation in moderate hypertension in pregnancy [Effets de la nifedipine et de l'atenolol sur les circulations foeto-maternelles en cas d'hypertension arterielle gravidique moderee]. Therapie 1990;45(6):525. 3035152
23. Ciraru-Vigneron N, Pruna A, Akposso K, Bonnin P, Kedra W, Mintz P, et al. Comparison of the effects of nefedipine and atenolol in the treatment of uncomplicated hypertension in pregnancy [Comparaison des effets de la nifedipine et de l'atenolol dans le traitement de l'hypertension arterielle gravidique non compliquée]. Therapie 1992;47(3):221. 3035153
24. Ciraru-Vigneron N, Pruna A, Mintz P, Bonnin P, Lefevre V, Beaufils M, et al. Comparison of nifedipine and atenolol in treatment of moderate pregnancy hypertension. Proceedings of the 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:340. 3035154
25. Mintz P, Ciraru-Vigneron N, Ravina JH, Pruna A, Idatte JH, Bonnin P, et al. Comparison of the effects of nifedipine and atenolol in the treatment of non-complicated hypertension in pregnancy [Comparaison des effets de la nifedipine et de l'atenolol dans le traitement de l'hypertension arterielle gravidique non compliquée]. Therapie 1989;44(6):461. 3035155
26. Jannet D, Carbonne B, Sebban E, Milliez J. Nicardipine vs metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial. International Journal of Gynecology & Obstetrics 1995;49:225. 3034956
27. Jannet D, Carbonne B, Sebban E, Milliez J. Nicardipine vs metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial. Obstetrics & Gynecology 1994;84:354-9. 3034957
28. Li CY, Lao TT, Yu KM, Wong SP, Leung CF. The effect of labetalol on mild pre-eclampsia. Proceedings of the 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:191. 3034959
29. Yuen FT, Mo YP, Yin LC, Terence L. A double-blind randomised placebo controlled trial of labetalol in the treatment of mild pregnancy induced hypertension. Proceedings of the 2nd International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1993; Hong Kong, Singapore. 1993. 3035159
30. Oumachigui A, Verghese M, Balachander J. A comparative evaluation of metoprolol and methyldopa in the management of pregnancy induced hypertension. Indian Heart Journal 1992;44:39-41. 3034961
31. Banerjee G, Chatterjee D, Chatterjee A, Mukherjee P, Das A. A randomized controlled trial on use of nimodipine in mild P.I.H. Journal of Obstetrics and Gynecology of India 2002;52(4):44-6. 3034963
32. Pandey K, Gupta N, Gupta R, Gupta S. Comparing obstetric outcome using labetalol/methyldopa in pregnancy induced hypertension. 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5-9; Hyderabad, Andhra Pradesh, India. 2011:46. 3035167
33. Molvi SN, Mir S, Rana VS, Jabeen F, Rauoof A. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: A prospective randomized study comparing labetalol with alpha methyldopa. Archives of Gynecology and Obstetrics 2012;285(6):1553-62. 3034965
34. Srivastava B, Usha R, Bhardwaj R, Gaur S, Joshi G, Nag P. Comparative study of efficacy and adverse effect of labetalol and methyldopa in patients with pregnancy -induced hypertension. Indian Journal of Pharmacology 2013; Vol. 45. 9246007
35. Aparna J. A randomized, double-blind, comparative trial of nifedipine and methyldopa in moderate pregnancy induced hypertension. Der Pharmacia Lettre 2013;5(4):274-7. 9246009
36. Subhedar V, Inamdar S, Hariharan C, Subhedar S. Comparison of efficacy of labetalol and methyldopa in patients with pregnancy-induced hypertension. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2013;2(1):27-34. 9246011
37. Babbar K, Armo M, Bhanja RL. A comparative study of efficacy of antihypertensive drugs and feto-maternal outcome in the treatment of pregnancy induced hypertension. Journal of Reproduction, Contraception, Obstetrics and Gynecology 2015;4(6):1846-52. 9246013
38. Singhal S, Gupta AK. A comparative randomized controlled parallel group study of efficacy and tolerability of labetalol versus methyldopa in the treatment of mild pre-eclampsia. Internatiional Journal of Basic and Clinical Pharmacology 2015; Vol. 4, issue 3:442-5. 9246015
39. Blake S, MacDonald D. The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment. British Journal of Obstetrics and Gynaecology 1991;98:244-8. 3034969
40. Ellenbogen A, Jaschevatzky O, Davidson A, Anderman S, Grunstein S. Management of pregnancy-induced hypertension with pindolol - comparative study with methyldopa. International Journal of Gynecology & Obstetrics 1986;24:3-7. 9246017
41. Jaschevatzky OE, Davidson A, Ellenbogen A, Anderman S, Grunstein S. Comparative study of pindolol and methyldopa and transplacental cross of pindolol in PIH. 5th International Congress of the International Society for the study of Hypertension in Pregnancy; 1986 7-10 July; Nottingham, England. 1986:137. 9246018
42. Rosenfeld J, Bott-Kanner G, Boner G, Nissenkorn A, Friedman S, Ovadia J, et al. Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol. European Journal of Obstetrics & Gynecology and Reproductive Biology 1986;22:197-204. 9246020
43. Bar J, Hirsch M, Friedman S, Fuchs J, Ovadia J, Bott-Kanner G. The effect of beta-adrenergic blocker pindolol on platelet function in chronic hypertensive pregnancies. Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 March 15-18; Sydney, Australia. 1994:155. 9246022
44. Bott-Kanner G, Hirsch M, Boner G, Ovadia J, Modan M, Friedmann S, et al. Evaluation of antihypertensive therapy (AHT) in the management of hypertension in pregnancy (HP). 6th International Congress of the International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada. 1988:11. 9246023
45. Bott-Kanner G, Hirsch M, Friedman S, Boner G, Ovadia J, Merlob P, et al. Antihypertensive therapy in the management of hypertension in pregnancy - a clinical double-blind study of pindolol. Clinical and Experimental Hypertension 1992;B11:207-20. 9246024
46. Hirsch M, Bar J, Bott-Kanner G, Kaplan B, Fuchs J, Ovadia J. Effect of the beta-adrenergic blocker pindolol on platelet function in chronic hypertensive pregnancy. Hypertension in Pregnancy 1996;15:193-202. 9246025
47. Paran E, Baile Y, Holzberg G, Masor M, Zmora E, Insler V. Treatment of hypertension in pregnancy: different regime, different outcome. 6th International Congress of the International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada. 1988:105. 3034981
48. Paran E, Holzberg G, Mazor M, Zmora E, Insler V. Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension. International Journal of Clinical Pharmacology and Therapeutics 1995;33:119-23. 3034982
49. Paran E, Maisner I, Holzberg G, Mazor M, Zmora E, Biale Y, et al. Beta-blocker treatment of PIH correlated with uteroplacental blood flow measurement. 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada. 1988:109. 3034983
50. Catalano D, Ercolano S, Pollio F, Ascione L, Russo C, De Santi B, et al. Evaluation of nifedipine monotherapy in the management of pregnancy hypertension [Valuazione della monoterapia con nifedipina nel management della gestosi EPH]. Giornale Italiano Di Ostetricia e Ginecologia 1997;6:373-5. 3034985
51. Bortolus R, Ricci E, Chatenoud L, Parazzini F. Nifedipine administered in pregnancy: effect on the development of children at 18 months. BJOG: an international journal of obstetrics and gynaecology 2000;107:792-4. 3034987
52. Gruppo di Studio Ipertensione in Gravidanza. Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. British Journal of Obstetrics and Gynaecology 1998;105:718-22. 3034988
53. Luchini L, Bortolus R, Parazzini F. Multicentric, randomized, clinical trial on the efficacy of long-acting nifedipine in improving the prognosis of pregnancy in women with mild or moderate chronic or pregnancy-induced hypertension. Journal of Nephrology 1991;6:51-4. 3034989
54. Neri I, Ternelli G, Facchinetti F, Volpe A. Effectiveness of oral nifedipine and transdermal glyceryltrinitrate on 24-hours blood pressure values in pregnancy-induced hypertension. Hypertension in Pregnancy 2000;19(Suppl 1):O65. 3034991
55. Neri I, Valensise H, Fachinetti F, Menghini S, Romanini C, Volpe A. 24-hour ambulatory blood pressure monitoring: a comparison between transdermal glyceryl-trinitrate and oral nifedipine. Hypertension in Pregnancy 1999;18:107-13. 3034992
56. Borghi C, Degli Esposti D, Cassani A, Immordino V, Bovicelli L, Ambrosioni E. The treatment of hypertension in pregnancy. Journal of Hypertension 2002;20(Suppl 2):S52-S56. 3034994
57. Borghi C, Immordino V, Degli Esposti D, Boschi S, Cassani A, Bentivenga C, et al. Comparison between nifedipine-gits and methyldopa on blood pressure control, utero-placental hemodynamic and fetal outcome in patients with pre-eclampsia. Hypertension in Pregnancy 2000;19(Suppl 1):P8. 3034995
58. Sharif N, Usman I, Azhar T. Pregnancy induced hypertension; to compare efficacy of methyldopa and labetalol in management. Professional Medical Journal 2016; Vol. 23, issue 10:1187-93. 9246027
59. Vigil-De Gracia P, Dominguez L, Solis A. Management of chronic hypertension during pregnancy with furosemide, amlodipine or aspirin: a pilot clinical trial. Journal of Maternal-Fetal & Neonatal Medicine 2014;27(13):1291-4. 9246029
60. Odendaal HJ, Schabort I, Pattinson RC. Prazosin for the treatment of hypertension in pregnancy: a randomized control trial. In: Oxford Database of Perinatal Trials, Version 1.2, Disk Issue 6, Autumn. Chalmers I (ed). Oxford: Oxford University Press.1991. 9246031
61. Eloff WJ. The use of nifedipine vs methyldopa in mild to moderate pregnancy associated hypertension. Proceedings of the 12th Conference on Priorities in Perinatal Care; 1993; South Africa. 1993:130-3. 3034999
62. Torres Pons PJ, Roca M, Codina C, Cobo E, Cararach V, Gonzalez-Merlo J. Labetalol in the treatment of mild hypertension in pregnancy. A double blind controlled trial. 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada. 1988:102. 3035242
63. Elhassan EM, Mirghani OA, Habour AB, Adam I. Methyldopa versus no drug treatment in the management of mild pre-eclampsia. East African Medical Journal 2002;71(4):172-5. 3035001
64. Bjorksten B, Finnstrom O, Wichman K. Intrauterine exposure to the beta-adrenergic receptor-blocking agent metoprolol and allergy. International Archives of Allergy and Immunology 1988;87:59-62. 3035003
65. Finnstrom O, Ezitis J, Ryden G, Wichman K. Neonatal effects of beta-blocking drugs in pregnancy. Acta Obstetricia et Gynecologica Scandinavica Supplement 1984;118:91-3. 3035004
66. Ryden G, Karlberg BE, Wichman K. Metoprolol in the treatment of hypertension in pregnancy - effect on the mother and foetus. 4th World Congress of the International Society for the study of Hypertension in Pregnancy; 1984 Jun 18-21; Amsterdam, The Netherlands. 1984:38. 3035005
67. Wichman K. Metoprolol in the treatment of mild to moderate hypertension in pregnancy - effects on fetal heart activity. Clinical and Experimental Hypertension 1986;5:195-202. 3035010
68. Wichman K, Ezitis J, Finnstrom O, Ryden G. Metoprolol in the treatment of hypertension in pregnancy - effect on the newborn baby. Clinical and Experimental Hypertension 1984;B3:153. 3035006
69. Wichman K, Ezitis J, Finnstrom O, Ryden G. Metoprolol in the treatment of hypertension in pregnancy - effects on the newborn baby. 4th World Congress of the International Society for the study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands. 1984:40. 3035007
70. Wichman K, Karlberg BE, Ryden G. Metoprolol in the treatment of mild to moderate hypertension in pregnancy - effects on the mother. Clinical and Experimental Hypertension 1985;B4:141-56. 3035008
71. Wichman K, Ryden G, Karlberg BE. A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Scandinavian Journal of Clinical and Laboratory Investigation 1984;106:90-5. 3035009
72. Hogstedt S, Lindberg B, Lindeberg S, Ludviksson K, Sandstrom B. Effect of metoprolol on fetal heart rate patterns during pregnancy and delivery. Clinical and Experimental Hypertension 1984;B3:152. 3035014
73. Högstedt S, Lindberg B, Lindberg S, Ludviksson K, Sandström B. Effect of metoprolol on fetal heart rate patterns during pregnancy and delivery. 4th World Congress of the International Society for the study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands. 1984:39. 3035012
74. Högstedt S, Lindeberg S, Axelsson O, Lindmark G, Rane A, Sandström B, et al. A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy. Acta Obstetricia et Gynecologica Scandinavica 1985;64:505-10. 3035013
75. Lindeberg S, Axelsson O, Lindeberg BS, Lindmark G, Ludviksson K, Sandström B. Effect of metoprolol in combination with hydralazine on fetal heart rate patterns during hypertensive pregnancy and delivery. Clinical and Experimental Hypertension 1985;4(1):87-94. 3035015
76. Wide-Swensson D, Ingemarsson I, Lunell NO, Lindberg B, Lindeberg S, Marsal K, et al. Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study. International Journal of Obstetrics & Gynecology 1994;46:3. 3035017
77. Wide-Swensson DH, Ingemarsson I, Lunell NO, Forman A, Skajaa K, Lindberg B. Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study. American Journal of Obstetrics and Gynecology 1995;173:872-8. 3035018
78. Leather HM, Humphreys DM, Baker P, Chadd MA. A controlled trial of hypotensive agents in hypertension in pregnancy. Lancet 1968;2:488-90. 3035020
79. Cockburn J, Moar VA, Ounsted MK, Redman CW. Final report on study of hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982;1:647-9. 3035022
80. Moar VA, Jefferies MA, Mutch LM, Ounsted MK, Redman CW. Neonatal head circumference and the treatment of maternal hypertension. British Journal of Obstetrics and Gynaecology 1978;85:933-7. 3035023
81. Mutch LM, Moar VA, Ounsted MK, Redman CW. Hypertension during pregnancy, with and without specific hypotensive treatment. I. Perinatal factors and neonatal morbidity. Early Human Development 1977;1:47-57. 3035024
82. Mutch LM, Moar VA, Ounsted MK, Redman CW. Hypertension during pregnancy, with and without specific hypotensive treatment. II The growth and development of the infant in the first year of life. Early Human Development 1977;1:59-67. 3035025
83. Ounsted M. The children of women who had hypertension during pregnancy. In: Rubin PC editor(s). Hypertension in Pregnancy. Amsterdam: Elsevier Science Publishers B.V, 1988:341-62. 3035026
84. Ounsted MK, Moar VA, Good FJ, Redman CW. Hypertension during pregnancy with and without specific treatment: the development of the children at the age of four years. British Journal of Obstetrics and Gynaecology 1980;87:19-24. 3035027
85. Redman CW, Beilin LJ, Bonnar J. Treatment of hypertension in pregnancy with methyldopa: blood pressure control and side effects. British Journal of Obstetrics and Gynaecology 1977;84:419-26. 3035029
86. Redman CW, Beilin LJ, Bonnar J, Ounsted MK. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 1976;2:753-6. 3035028
87. Lamming GD, Pipkin FB, Symonds EM. Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension. Clinical and Experimental Hypertension 1980;2:865-95. 3035031
88. Lamming GD, Symonds EM. Comparison of the alpha and beta blocking drug labetalol and aldomet in the treatment of pregnancy induced hypertension. Proceedings of the 2nd Congress of the International Society for the Study of Hypertension in Pregnancy; 1980 December 1-4; Cairo, Egypt. 1980:9. 3035032
89. Lamming GD, Symonds EM. Use of labetalol and methyldopa in pregnancy-induced hypertension. British Journal of Clinical Pharmacology 1979;8:217S-222S. 3035033
90. Cameron AD, Walker JJ, Bonduelle M, Calder AA. A randomised trial of the antihypertensive agent, labetalol, against bed rest in pregnancy hypertension. Archives of Gynecology 1985;237(Suppl 1):295. 3035035
91. Lang GD, Lowe GD, Walker JJ, Forbes CD, Calder AA. Increased blood viscosity in pre-eclampsia: effect of treatment with labetalol. Thrombosis and Haemostasis 1983;50:156. 3035036
92. Lang GD, Lowe GD, Walker JJ, Forbes CD, Prentice CR, Calder AA. Blood rheology in pre-eclampsia and intrauterine growth retardation: effects of blood pressure reduction with labetalol. British Journal of Obstetrics and Gynaecology 1984;91:438-43. 3035037
93. Walker J. Intrauterine Growth Retardation and Maternal Labetalol Treatment in a Random Allocation Controlled Study [MD thesis]. Scotland: University of Glasgow, 1992:141-55. 3035038
94. Walker JJ, Crooks A, Erwin L, Calder AA. Labetalol in pregnancy-induced hypertension: fetal and maternal effects. In: Reilly A, Symonds EM editor(s). International Congress Series 591. Amsterdam: Excerpta Medica, 1982:148-60. 3035039
95. Reynolds B, Butters L, Evans J, Adams T, Rubin PC. First year of life after the use of atenolol in pregnancy associated hypertension. Archives of Disease in Childhood 1984;59:1061-3. 9246033
96. Rubin PC, Butters L, Clark D, Sumner D, Belfield A, Pledger D, et al. Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol. American Journal of Obstetrics and Gynecology 1984;150:389-92. 9246034
97. Rubin PC, Butters L, Clark DM, Low RA, Reid JL. Atenolol in the management of hypertension during pregnancy. Drugs 1983;25:212-4. 9246035
98. Rubin PC, Butters L, Clark DM, Reynolds B, Sumner DJ, Steedman D. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet 1983;1:431-4. 9246036
99. Rubin PC, Butters L, Reynolds B, Low RAL. Atenolol in the management of pregnancy associated hypertension: obstetric and paediatric aspects. 4th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands. 1984:41. 9246037
100. Fidler J, Smith V, Fayers P, de Swiet M. Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. British Medical Journal 1983;286:1927-30. 9246039
101. Fidler J, Smith V, Fayers P, de Swiet M. Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. Obstetrical and Gynecological Survey 1983;286:202-5. 9246040
102. Thorley KJ. Atenolol: side effects in the newborn infant. British Medical Journal 1982;285:1116. 3035050
103. Thorley KJ. Randomised trial of atenolol and methyl dopa in pregnancy related hypertension. 4th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands. 1984:53. 3035052
104. Thorley KJ. Randomised trial of atenolol and methyl dopa in pregnancy related hypertension. Clinical and Experimental Hypertension 1984;133:168. 3035051
105. Pickles C, Symonds E, Brinkman C. Effects of labetalol (L) vs placebo (P) on arterial pressure (AP) and forearm venous distensibility (FVD) in women with pregnancy induced hypertension (PIH). 5th International Congress of the International Society for the study of Hypertension in Pregnancy; 1986 7-10 July; Nottingham, England. 1986:92. 3035054
106. Pickles CJ, Broughton Pipkin F, Symonds EM. A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension. Britisth Journal of Obstetrics and Gynaecology 1992;99:964-8. 3035055
107. Pickles CJ, Symonds EM, Broughton Pipkin F. The fetal outcome in a randomized double-blind controlled trial of labetalol vs placebo in pregnancy-induced hypertension. British Journal of Obstetrics and Gynaecology 1989;96:38-43. 3035056
108. Pickles CJ, Symonds EM, Broughton Pipkin F. The fetal outcome of early intervention therapy in pregnancy induced hypertension. A randomised, double-blind controlled trial of labetalol vs placebo. 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada. 1988:107. 3035057
109. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ 1990;301:587-9. 3035059
110. Cruickshank DJ, Campbell D, Robertson AA, MacGillivray I. Intra-uterine growth retardation and maternal labetalol treatment in a random allocation controlled study. Journal of Obstetrics and Gynaecology 1992;12:223-7. 3035061
111. Cruickshank DJ, Campbell DM. Atenolol in essential hypertension during pregnancy. BMJ 1990;301:1103. 3035062
112. Cruickshank DJ, Robertson AA, Campbell DM, MacGillivray I. Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomised controlled study. European Journal of Obstetrics & Gynecology and Reproductive Biology 1992;45:47-51. 3035063
113. Cruickshank DJ, Robertson AA, Campbell DM, MacGillivray I. Maternal obstetric outcome measures in a randomised controlled study of labetalol in the treatment of hypertension in pregnancy. Clinical and Experimental Hypertension 1991;B10:333-4. 3035064
114. NCT00141310 . A randomised, double-blind, placebo-controlled, flexible-dose, parallel-group study to evaluate the efficacy, safety and toleration of oral sildenafil citrate administered in the dose range of 20 - 80 mg TID for the treatment of pre-eclampsia. (PET). clinicaltrials.gov/ct2/show/record/NCT00141310 (first received: 30 August 2005). 9246042
115. Samangaya RA, Mires G, Shennan A, Skillern L, Howe D, McLeod A, et al. A randomised, double-blinded, placebo-controlled trial of the phosphodiesterase type 5 inhibitor sildenafil in the treatment of preeclampsia. Hypertension in Pregnancy 2009;28:369-82. 9246043
116. Samangaya RA, Wareing M, Skillern L, Baker PN. Phosphodiesterase inhibitor effect on small artery function in preeclampsia. Hypertension in Pregnancy 2011;30(2):144-52. 9246044
117. EUCTR2013-003144-23-GB . Pregnancy and chronic hypertension: nifedipine or labetalol as antihypertensive treatment - PANDA. clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-003144-23 (first received 30 October 2013). 9246046
118. Webster L, Gill C, Seed P, Bramham K, Wiesender C, Nelson-Piercy C, et al. Effect of antihypertensive treatment on placental, renal and endothelial biomarkers in pregnancy complicated by chronic hypertension. BJOG: an international journal of obstetrics and gynaecology 2017;124:12. 9246047
119. Webster L, Myers J, Nelson-Piercy C, Watt-Coote I, Wiesender C, Seed PT, et al. Pregnancy and chronic hypertension: Nifedipine vs labetalol as antihypertensive treatment (the PANDA study). Pregnancy Hypertension 2016;6:141. 9246048
120. Webster LM, Myers JE, Nelson-Piercy C, Harding K, Cruickshank JK, Watt-Coote I, et al. Labetalol versus nifedipine as antihypertensive treatment for chronic hypertension in pregnancy: a randomized controlled trial. Hypertension 2017;70(5):915-22. 9246049
121. Webster LM, Myers JE, Nelson-Piercy C, Watt-Coote I, Wiesender C, Seed PT, Chappell LC. Pregnancy and chronic hypertension: Nifedipine vs labetalol as antihypertensive treatment (the Panda study). Ophthalmology 2016;6(3):141. 9246050
122. Arias F, Zamora J. Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension. Obstetrics & Gynecology 1979;53:489-94. 3035066
123. Sibai BM, Gonzalez AR, Mabie WC, Moretti M. A comparison of labetalol plus hospitalization vs hospitalization alone in the management of preeclampsia remote from term. Obstetrics & Gynecology 1987;70:323-7. 9246052
124. Weitz C, Khouzami V, Maxwell K, Johnson JW. Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study. International Journal of Gynecology & Obstetrics 1987;25:35-40. 9246054
125. Sibai BM. The need of hypertensive drugs in management of mild to moderate pregnant hypertension. Proceedings of the 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:133. 9246057
126. Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication vs methyldopa or labetalol in chronic hypertension during pregnancy. American Journal of Obstetrics and Gynecology 1990;162:960-7. 9246056
127. Barton JR, Mercer BM, Sibai BM. The effect of nifedipine on urinary excretion of calcium in preeclampsia. American Journal of Perinatology 1997;14:609-12. 3035075
128. Sibai BM, Barton JR, Akl S, Sarinoglu C, Mercer BM. A randomized prospective comparison of nifedipine and bed rest vs bed rest alone in the management of preeclampsia remote from term. Amercian Journal of Obstetrics and Gynecology 1992;167:879-84. 3035076
129. Sibai BM, Barton JR, Akl S, Sarinoglu C, Mercer BM. A randomized prospective comparison of nifedipine and bed rest vs bed rest alone in the management of preeclampsia remote from term. American Journal of Obstetrics and Gynecology 1992;166:280. 3035077
130. Faneite PJ, Gonzalez X, Salazar G. Evaluation of antihypertensives in pregnancy: prospective randomized study of mepindolol and alpha methyldopa [Evaluación de antihipertensivos en embarazadas: Mepindolol y alfametildopa. Estudio prospectivo y randomizado]. Revista de Obstetricia y Ginecologia de Venezuela 1988;48:139-43. 3035079
131. Voto LS, Quiroga CA, Lapidus AM, Catuzzi P, Uranga IF, Margulies M. Effectiveness of antihypertensive drugs in the treatment of hypertension in pregnancy. Clinical and Experimental Hypertension - Part B Hypertension in Pregnancy 1990;9(3):339-48. 3035081
132. Fabregues G, Sure P, Knaudt S, Gonzalez Pena J, Esper R. The use of atenolol to prevent preeclampsia and superimposed preeclampsia. International Journal of Gynecology & Obstetrics 1994;46:95. 3035083
133. Henderson-Smart DJ, Horvath JS, Phippard A, Korda A, Child A, Duggin GG, et al. Effect of antihypertensive drugs on neonatal blood pressure. Clinical and Experimental Pharmacology and Physiology 1984;11(4):351-4. 9246059
134. Horvath JS, Henderson-Smart DJ, Phippard A, Korda A, Child A, Duggin GG, et al. The effect of antihypertensive drugs on neonatal blood pressure. 4th World Congress of the International Society for the study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands. 1984:42. 9246060
135. Horvath JS, Phippard A, Korda A, Henderson-Smart D, Child A, Duggin GG, et al. A controlled trial comparing clonidine hydrochloride and alpha methyl dopa in pregnant women with hypertension. 4th World Congress of the International Society for the study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands. 1984:246. 9246061
136. Horvath JS, Phippard A, Korda A, Henderson-Smart DJ, Child A, Tiller DJ. Clonidine hydrochloride - a safe and effective antihypertensive agent in pregnancy. Obstetrics & Gynecology 1985;66:634-8. 9246062
137. Horvath JS, Phipparel A, Korda A, Henderson-Smart D, Child A, Duggin GG, et al. A controlled trial comparing clonidine hydrochloride and alpha methyl dopa in pregnant women [abstract]. Kidney International 1984;26(2):233. 9246063
138. Phippard A, Fisher W, Child A, Henderson-Smart D, Horvarth J, Korda A, et al. A randomized, placebo-controlled study on the effect of therapy for mild to moderate hypertension in primigravidae. 6th International Congress of the International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada. 1988:112. 3035091
139. Phippard AF, Fischer WE, Horvath JS, Child AG, Korda AR, Henderson-Smart DJ, et al. Early blood pressure control improves pregnancy outcome in primigravid women with mild hypertension. Medical Journal of Australia 1991;154:378-82. 3035092
140. Loquet P, Buytaert P, Renier M. The influence of pindolol and atenolol on serial feto-placental blood flow measurements in non-proteinuric hypertension in pregnancy. 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada. 1988:111. 3035094
141. Renier M, Loquet P, Buytaert P. The influence of pindolol and atenolol on serial feto-placental blood flow measurements in non-proteinuric hypertension in pregnancy. Proceedings of the 11th European Congress of Perinatal Medicine;1988 April 10-13; Rome, Italy. 1988. 3035095
142. Pereira TS, Pereira CI, Junior JA, Netto HC. Influence of nifedipine on the fetal placental flow. Jornal Brasileiro de Ginecologia 1997;107(10):371-80. 3035097
143. Alves EA. Estudo prospectivo, comparativo da Isradipina e Atenolol no tratamento de gestantes hipertensas [Prospective, comparative study of isradipine and atenolol for the treatment of hypertensive pregnant women] [Doctoral Thesis]. Faculty of Medicine, University of São Paulo, 1998. 9246065
144. Darcie S, Leone CR, Calil VM, Prescinotti EP, Kahhale S, Zugaib M. Glycemia in newborns of hypertensive mothers according to maternal treatment [Glicemia no recém-nascido de mäe hipertensas de acordo com a terapêutica materna]. Revista do Hospital das Clínicas 2004;59(5):244-0. 9246066
145. Kahhale S, Alves EA, Takiuti NH, Zugaib M. Efficacy and safety of isradipina and atenolol in hypertensive disorders in pregnancy [abstract]. Hypertension in Pregnancy 2000;19(1):98. 9246067
146. Leone CR, Calil VM, Darcie S, Prescinotti EP, Kahhale S, Zugaib M. Growth of newborn of the mothers with hypertension during the first year of life: therapeutics in pregnancy on the newborn [Crescimento de recém-nascidos de mäes hipertensas durante o primeiro ano de vida: influência da terapêutica materna]. Revista Paulista de Pediatría 2003;21(1):19-26. 9246068
147. Vasconcellos MJ, Chaves Netto H, Kahhale S. Incidence of small fetuses for the gestational age among chronic hypertensive women in use of verapamil (chronic oral use). Hypertension in Pregnancy 2000;19(Suppl 1):P166. 9246072
148. Vasconcellos MJ, Chaves Netto H, Kahhale S. Verapamil: its effect on placental circulation in mild to moderate chronic hypertensive pregnant women. Hypertension in Pregnancy 2000;19(Suppl 1):P163. 9246073
149. Vasconcellos MJ, Chaves Netto H, Kahhale S, Almeida PJ. Use of verapamil in chronic hypertensive pregnant women: flow analysis of uterine and umbilical artery [Uso do verapamil em gestantes hipertensas crônicas: análise do fluxo das artérias uterinas e umbilical]. Revista Brasileira de Ginecologia é Obstetrícia 2000;22(5):265-74. 9246070
150. Vasconcellos MJ, Chaves Netto H, Kahhale S, Almeida PJ. Verapamil use in chronic hypertension pregnant women. XVI FIGO World Congress of Obstetrics and Gynaecology; 2000 Sept 3-8; Washington DC. Book 2. 2000:46. 9246071
151. Qian XH, Huang YL, Wu SP. Treatment of hypertension syndrome of pregnancy with ligustrazine. Chung Hsi I Chieh Ho Tsa Chih 1991;11(9):533-4, 516. 3035109
152. Hong YJ, Lin CF, Chen JC, Pan P, Wong KL, Wei TT. Nifedipine in preeclampsia for cesarean section. Ma Tsui Hsueh Tsa Chi (Acta Anaesthesiologica Sinica) 1993;31(1):43-8. 3035111
153. Li M, Yang M, Qiu X. The effect of nimodipine on retinal blood flow in pregnancy induced hypertension. Chung-Hua Fu Chan Ko Tsa Chih 1998;33(7):397-9. 3035113
154. Wang Z, Song H. Clinical observation on therapeutical effect of prepared rhubarb in treating pregnancy induced hypertension. Chung-Kuo Chung Hsi i Chieh Ho Tsa Chih 1999;19:725-7. 3035115
155. Yang X, Liu Y. The effect of nifedipine on postpartum blood loss in patients with pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 2000;35(3):151-2. 3035117
156. Sun X, Wang K, Wang W, Li B. Clinical study on sildenafil in treatment of pregnant women with pulmonary arterial hypertension [Article in Chinese]. Zhonghua Fu Chan Ke Za Zhi 2014;49(6):414-8. 9246075
157. Xiao S, Zhang M, Liang Y, Wang D. Celastrol synergizes with oral nifedipine to attenuate hypertension in preeclampsia: a randomized, placebo-controlled, and double blinded trial. Journal of the American Society of Hypertension 2017;11(9):598-603. 9246077
158. Gómez Sosa E, Miró Maceo M, Alcade MT. Mild chronic hypertension: antihypertensive medication and maternal and perinatal results [Hipertensión crónica moderada: medicación antihipertensiva y resultados maternos y perinatales]. Revista Cubana de Medicina General Integral 1994;10(4):340-3. 3035119
159. Soucek M, Prasek J, Spinarova L. Atenolol and bisoprolol in the treatment of mild and moderately severe hypertension [Atenolol a bisoprolol v lécbe mírné a stredne tezké hypertenze]. Vnitrni Lekarstvi 1993;39(6):541-8. 3035121
160. Rudnicki M, Frölich A, Fischer Rasmussen W, McNair P. The effect of magnesium on maternal blood pressure in pregnancy-induced hypertension. Acta Obstetricia et Gynecologica Scandinavica 1991;70:445-50. 3035123
161. Rudnicki M, Frölich A, Fischer-Rasmussen W. Magnesium supplement in pregnancy-induced hypertension: effects on maternal and neonatal magnesium and calcium homeostasis. Mineral and Electrolyte Metabolism 1991;17(6):399-403. 3035124
162. Rudnicki M, Junge J, Frölich A, Ornvold K, Fischer-Rasmussen W. Magnesium supplement in pregnancy-induced hypertension. A clinicopathological study. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica 1990;98(12):1123-7. 3035125
163. Rudnicki M, Frølich A, Pilsgaard K, Nyrnberg L, Møller M, Sanchez M, et al. Comparison of magnesium and methyldopa for the control of blood pressure in pregnancies complicated with hypertension. Gynecologic and Obstetric Investigation 2000;49:231-5. 3035127
164. Cid-Troncoso J, Pérez-Pérez M, Jiménez JA, Núñez-Diplan AM, Balbi M, Santana E. Nifedipine retard vs methyldopa in chronic hypertension with superimposed toxemia [Nifedipina retard vs. alfa-metil-dopa en la hipertensión arterial crónica mas toxemia agregada]. Revista Médica Dominicana 1992;53(2/3):76-8. 9246079
165. Deschamps C, Guzman P, Mejia M, Sanchez Ramirez PB, Sanchez Beltre JE, Gomez Hernandez J. Comparison of hydralazine and alpha methyldopa in hypertension in pregnancy [Comparacion de hidralazina y alfametildopa en la hipertension durante el embarazo]. Acta Medica Dominicana 1992;14(6):222-4. 9246081
166. Salem HT, Ghanemah S, Seleem S, Sayed EH, Abdel-Latif A, Chard T. Bromocriptine therapy in pre-eclamptic toxaemia of pregnancy (PET). World Congress of Gynecology and Obstetrics; 1988 October 23-28; Brazil. 1988:184. 3035133
167. Ismail AA, Medhat I, Tawfic TAS, Kholeif A. Evaluation of calcium-antagonist (Nifedipine) in the treatment of pre-eclampsia. International Journal of Gynecology & Obstetrics 1993;40:39-43. 3035135
168. Salem HT, Salah M, Kotb HI, Makarem MH, Mostafa SA, Mohamed SA. The use of specific opioid receptor antagonist (Naltrexone) in hypertensive pregnancy. Research Activities on Reproductive Health. Assiut: Assiut University, Faculty of Medicine, 1997:74. 3035137
169. Tanbouli T, Mawsouf MN, Re L, Martinez-Sanchez G, Saaed G, El SM, et al. Effect of ozone therapy on foetoplacental blood flow in hypertensive pregnant women. International Journal of Ozone Therapy 2009;8(2):211-6. 3035139
170. Abbas AM, NCT03213639 . Use of esomeprazole in treatment of early onset preeclampsia:a double blind randomized, placebo-controlled trial. clinicaltrials.gov/show/NCT03213639 (first received 21 Augsut 2017). 9246083
171. Tuimala R, Hartikainen-Sorri AL. Randomised comparison of atenolol and pindolol for treatment of hypertension in pregnancy. Current Therapeutic Research 1988;44(4):579-84. 9246085
172. Tuimala R, Hartikainen-Sorri AL. Treatment of hypertension during pregnancy by beta blocking agents. 4th World Congress of the International Society for the study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands. 1984:52. 9246086
173. Räsänen J, Joupilla P. Uterine and fetal hemodynamics and fetal cardiac function after atenolol and pindolol infusion. A randomized study. European Journal of Obstetrics & Gynecology and Reproductive Biology 1995;62:195-201. 3035146
174. Laivuori HM, Laakso M, Tikkanen MJ, Cacciatore B, Ylikorkala RO, Kaaja Rj. Short-term metabolic effects of isradipine and metoprolol in pre-eclampsia. Journal of Hypertension 1999;17(8):1189-94. 3035148
175. Fievet P, El Esper N, Gueroult JF, Gueroult JC, Fournier A. Comparative study of clonidine and labetalol in severe hypertension induced by pregnancy. Congress of the International Society for the Study of Hypertension in Pregnancy. 7-10 July 1986; Vol. Nottingham, England:136. 9246088
176. Madonna O, M'Pio I, Labeeuw M, Pozet N, Zech P. Evaluation of renal function in pregnant hypertensives under treatment. A comparison between methyldopa, pindolol and atenolol. 6th International Congress of the International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada. 1988:260. 9246090
177. Groten T, Fitzgerald J, Lehmann T, Schneider U, Kahler C, Schleussner E. Reduction of preeclampsia related complications with the NO-donor penterythriltetranitrat (petn) in risk pregnancies - A prospective randomized double-blind placebo pilot study. Pregnancy Hypertension 2012;2(3):181. 3035157
178. Tamás P, Csermely T, Ertl T, Vizer M, Szabó I, Prievara FT. Calcium dobesilate lowers the blood pressure in mild to moderate midtrimester hypertension: a pilot study. Gynecologic and Obstetric Investigation 1999;47:210-3. 3035161
179. Tamás P, Csermely T, Szabó EI. Doxium - a novel drug in the management of gestational hypertension?. 16th European Congress of Perinatal Medicine; 1998 June 10-13; Zagreb. 1998. 3035162
180. Tamás P, Szabó I, Szekely J, Csermely T, Prievara FT, Nemeth L, et al. Effects of doxium 500(tm) in gestational hypertension [A Doxium 500 (R) hatasanak vizgalata terhessegi hypertoniaban (kettos vak, placebo-kontrollalt tanulmany)]. Magyar Noorvosok Lapja 1997;60:181-7. 3035163
181. Shenoy S, Chandrika D, Pisharody R. RCT of low dose aspirin to prevent the progression of pregnancy induced hypertension grade A to B. Journal of Clinical Epidemiology 1999;52(Suppl 1):28S. 3035165
182. Verma R, Lahon K, TonpaY SD, Kale VJ. A comparative randomised controlled parallel group study of maternal, fetal and neonatal outcomes of labetalol versus methyldopa in the treatment of new onset hypertension during pregnancy. International Journal of Pharma & Bio Sciences 2012;3(1):201-11. 9246091
183. Verma R, Lahon K, Tonpay SD, Kale VJ, Jaim DK. A comparative randomised controlled parallel group study of efficacy and tolerability outcomes of labetalol versus methyldopa in the treatment of new onset hypertension during pregnancy. International Journal of Life Science & Pharma Research 2012;2(1):L23-31. 9246092
184. Dasgupta S. Does prophylactic magnesium sulphate in mild preeclampsia reduce umbilical artery pulsatility index? A randomized placebo controlled trial. Clinical Trials Registry - India (http://www.ctri.nic.in) (accessed 8 July 2011) 2011. 3035172
185. Dasgupta S, Ghosh D, Seal SL, Kamilya G, Karmakar M, Saha D. Randomized controlled study comparing effect of magnesium sulfate with placebo on fetal umbilical artery and middle cerebral artery blood flow in mild preeclampsia at >= 34 weeks gestational age. Journal of Obstetrics and Gynaecology Research 2012;38(5):763-71. 3035171
186. Bracken H. Oral antihypertensive regimens for management of hypertension in pregnancy. clinicaltrials.gov/ct2/show/NCT01912677 (first received 29 July 2013). 9246094
187. Mundle S, CTRI/2013/08/003866 . Oral antihypertensive regimens for management of hypertension in pregnancy. http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=7167 (first received 2 August 2013). 9246095
188. Easterling T, Bracken H, Mundle S, Magee L, vonDadelszen P, Winikoff B. Oral antihypertensive regimens for management of severe hypertension in pregnancy: Results from a pilot study in India. Pregnancy Hypertension 2015;5(1):120. 9246097
189. Gainder S, Thakur M, Saha SC, Prakash M. To study the changes in maternal and fetal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension. Pregnancy Hypertension 2015;5(1):30. 9246099
190. Mujawar JR, Patel SS. Circulating biomarkers of oxidative stress in preeclampsia and efficacy of antioxidant vitamin C supplementation. Research Journal of Pharmaceutical, Biological and Chemical Sciences 2016;7(1):1498-506. 9246101
191. Yassae F. A comparison of the effect of nifedipine and hydralazine in treatment of pregnancy induced hypertension. XVI FIGO World Congress of Obstetric and Gynecology (Book 3); 2000 Sept 3-8; Washington DC, USA. 2000:93. 3035174
192. Ghahiri A, Berjis K. A comparison between intravenous magnesium sulfate and oral magnesium chloride in mild preeclampsia. Journal of Research in Medical Sciences 2005;10(1):6-9. 3035176
193. NCT01674127 . Effect of methyldopa on uterine artery diameter in pregnant women with mild preeclampsia. clinicaltrials.gov/ct2/show/record/NCT01674127 (first received 24 August 2012). 9246103
194. IRCT201602067676N5 . Pregnancy outcomes with chronic hypertension on different antihypertensive therapy. http://en.search.irct.ir/view/28468 (first received 23 February 2016). 9246105
195. Davidson A, Ellenbogen A, Jaschevatzky O, Attias Y, Anderman S, Grunstein S. Randomized comparison of pindolol and atenolol for treatment of hypertension during pregnancy. 6th International Congress of the International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada. 1988:99. 3035178
196. Meizner I, Paran E, Katz M, Holcberg G, Insler V. Flow velocity analysis of umbilical and uterine artery flow in pre-eclampsia treated with propranolol or pindolol. Journal of Clinical Ultrasound 1992;20:115-9. 9246107
197. Thaler I, Amit A, Kamil D, Itskovitz-Eldor J. The effect of isosorbide dinitrate on placental blood flow and maternal blood pressure in women with pregnancy induced hypertension. American Journal of Hypertension 1999;12(4):341-7. 3035182
198. Martinelli P, Ferrara LA, Pasanisi F, Arpaia F, Paladini D, Mancini M. Nifedipine and atenolol in the treatment of pregnancy associated hypertension. 5th International Congress of the International Society for the Study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, England. 1986:128. 3035184
199. Pello L. Multicentric trial on the treatment of the hypertension in pregnancy [Ricerca multicéntrica sul trattamento del'ipertenzione in gravidanza]. Personal communication 1988. 9246109
200. Marlettini MG, Crippa S, Morselli-Labate AM, Contarini A, Orlandi C. Randomised comparison of calcium antagonists and beta-blockers in the treatment of pregnancy-induced hypertension. Current Therapeutic Research, Clinical and Experimental 1990;48(4):684-94. 9246111
201. Orlandi C, Marlettini MG, Cassani A, Crippa S. Antihypertensive therapy in pregnancy. Proceedings of the 11th European Congress of Perinatal Medicine; 1988; Rome, Italy. 1988:271. 9246112
202. Di Iorio R, Horvath S, Marinoni E, Manzari G, Martinico E, Bresadola M. Use of a thromboxane receptor inhibitor in pregnancy-induced hypertension. Proceedings of the 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990. 9246114
203. Picciolo C, Roncaglia N, Neri I, Pasta F, Arreghini A, Facchinetti F. Nitric oxide in the prevention of pre-eclampsia. Prenatal and Neonatal Medicine 2000;5:212-5. 3035191
204. Scarpellini F, Sbracia M, Lecchini S, Bolis P. Nitric oxide donor treatment reduces apoptosis in placental vessels of pregnancy induced hypertension [abstract]. American Journal of Obstetrics and Gynecology 2001;185(6 Suppl):S177. 3035193
205. Neri I, Venturini P, Battista Allais G, Facchinetti F. Acupuncture plus alfa-metildopa in the treatment of chronic hypertension: a protocol design [abstract]. Hypertension in Pregnancy 2004;23(Suppl 1):54. 3035195
206. Facchinetti F, Piccinini F, Pizzi C, Bukowski R, Volpe A, Saade G. Effect of arginine supplementation in patients with gestational hypertension. American Journal of Obstetrics and Gynecology 2002;187(6):S213. 3035197
207. Neri I, Blasi I, Facchinetti F. Effects of acute L-arginine infusion on non-stress test in hypertensive pregnant women. Journal of Maternal-Fetal & Neonatal Medicine 2004;16(1):23-6. 3035198
208. Neri I, Jasonni VM, Gori GF, Blasi I, Facchinetti F. Effect of L-arginine on blood pressure in pregnancy-induced hypertension: a randomized placebo-controlled trial. Journal of Maternal-Fetal and Neonatal Medicine 2006;19(5):277-81. 3035199
209. Noris M, Fratelli N, Rampello S, Gherardi G, Platto C, Todeschini M, et al. A double-blind, randomized, pilot study on L-arginine oral supplementation in pre-eclamptic pregnancies. Hypertension in Pregnancy 2008;27(4):505. 3035201
210. Neri I, Monari F, Sgarbi L, Berardi A, Masellis G, Facchinetti F. L-Arginine supplementation in women with chronic hypertension: Impact on blood pressure and maternal and neonatal complications. Journal of Maternal-Fetal and Neonatal Medicine 2010;23(12):1456-60. 3035203
211. Vasapollo B, Novelli GP, Gagliardi G, Tiralongo GM, Pisani I, Manfellotto D, et al. Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular resistance and influences maternal and fetal complications. Ultrasound in Obstetrics & Gynecology 2012;40(3):325-31. 9246116
212. Makino Y, Izumi H, Makino I, Shirakawa K. The effect of nitric oxide on uterine and umbilical artery flow velocity waveform in pre-eclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology 1997;73(2):139-43. 3035205
213. Koneoh E, JPRN-UMIN000020686 . Statin therapy for preeclampsia. upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023870 (date received 22 January 2016). 9246118
214. JPRN-UMIN000027270 . A study on prevention of hypertensive disorders of pregnancy who have a history of severe hypertensive disorders of pregnancy -pre-test for multi center trial. upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031037 (first received 15 May 2017). 9246120
215. El-Qarmalawi AM, Morsy AH, Al-Fadly A, Obeid A, Hashem M. Labetalol vs methyldopa in the treatment of pregnancy-induced hypertension. International Journal of Gynecology & Obstetrics 1995;49:125-30. 3035207
216. Lopez-Molina K, Gonzalez-Altamirano JC, Valdivia-Silva JE. Early L-arginine therapy improves notably the fetal growth in preeclamptic women. A randomized controlled trial. 55th Annual Meeting of the Society of Gynecologic Investigation; 2008 March 26-29; San Diego, USA 2008:Abstract no: 801. 3035209
217. EUCTR2014-002524-27-NL . A randomized, placebo-controlled, double blind, 4-period, cross-over trial, to study blood pressure lowering effects of losartan, Moxonidine and Low sodium diet in former pre-eclamptic women - PALM study. clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-002524-27 (first received 18 December 2014). 9246122
218. Gilani A, Khan Z. Role of aspirin in management of pregnancy induced hypertension. A study in Pakistani population. Specialist 1994;10(4):323-5. 3035211
219. Reyes OA, NCT01538875 . Hydralazine vs. labetalol for the management of hypertensive crisis in patients with hypertensive disorders of pregnancy. a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01538875 (first received 24 February 2012). 3035213
220. Decano MB, Cabrera LT. The effects of transdermal nitroglicerin (nitrol patch) on the uterine and umbilical artery blood flow in preeclampsia: a randomized double blind placebo controlled study. XVI Figo World Congress of Obstetric and Gynecology (Book 1); 2000 Sept 3-8; Washington DC, USA. 2000:26. 3035215
221. Osadchaia OV, Nazarenko LG, Bobritskaia VV. The clinical and hemodynamic aspects of using peripheral vasodilators in hypertension in pregnant women [Klinicheskie i gemodinamicheskie aspekty primeneniia perifericheskikh vazodilatorov pri gipertenzii beremennykh]. Akusherstvo i Ginekologia 1993;1993(2):16-20. 3035217
222. Montan S, Anandakumar C, Arulkumaran S, Ingemarsson I, Ratnam SS. Randomised controlled trial of methyldopa and isradipine in preeclampsia - effects on uteroplacental and fetal hemodynamics. Journal of Perinatal Medicine 1996;24:177-84. 3035219
223. Wide-Swensson D, Montan S, Arulkumaran S, Ingemarsson I, Ratnam SS. Effect of methyldopa and isradipine on fetal heart rate pattern assessed by computerized cardiotocography in human pregnancy. American Journal of Obstetrics and Gynecology 1993;169:1581-5. 3035220
224. Yin KH, Koh SC, Malcus P, Montan S, Biswas A, Arulkumaran S, et al. Preeclampsia: haemostatic status and the short-term effects of methyldopa and isradipine therapy. Journal of Obstetrics and Gynaecology Research 1998;24(3):231-8. 3035222
225. Sirotiaková J, Mlyncek M, Kriska M, Letkovicová M. Acebutolol in the treatment of arterial hypertension in pregnancy--comparison with commonly used hypertensive agents [Acebutolol v liecbe arteriovej hypertenzie v gravidite--porovnanie s bezne uzivanymi antihypertenzivami]. Ceska Gynekologie 2002;67(1):8-15. 3035224
226. Lindow SW, Davies N, Davey DA, Smith JA. The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy. British Journal of Obstetrics and Gynaecology 1988;95:1276-81. 3035226
227. Anthony J, Rees AE, Davey DA. Indoramin in the treatment of pregnancy hypertension. South African Medical Journal 1990;78:458-61. 3035228
228. Puzey MS, Ackovic KL, Lindow SW, Gonin R. The effect of nifedipine on fetal umbilical artery Doppler waveforms in pregnancies complicated by hypertension. South African Medical Journal 1991;79:192-4. 9246124
229. Steyn DW, Odendaal HJ. Blood pressure patterns in pregnant patients on oral ketanserin. Cardiovascular Journal of Southern Africa 2001;12(2):82-7. 3035233
230. Steyn DW, Odendaal HJ. Fetal heart baseline variability in patients on oral ketanserin. 10th World Congress of the International Society for the Study of Hypertension in Pregnancy;1996 August 4-8; Seattle, Washington, USA. 1996:171. 3035234
231. Steyn DW, Odendaal HJ. Maternal outcome six years after presenting with mild to moderate mid-trimester hypertension during pregnancy. 21st Conference on Priorities in Perinatal Care in South Africa; 2002 March 5-8; Eastern Cape, South Africa. 2002. 3035236
232. Steyn DW, Odendaal HJ. Maternal outcome six years after presenting with mild to moderate mid-trimester hypertension during pregnancy. Hypertension in Pregnancy 2002;21(Suppl 1):9. 3035235
233. Steyn DW, Odendaal HJ. Oral ketanserin in mild midtrimester hypertension - a randomised controlled trial. Proceedings of the 16th Conference on Priorities in Perinatal Care; 1997; South Africa. 1997:88-9. 3035237
234. Steyn DW, Odendaal HJ. Oral ketanserin plus aspirin decrease the incidence of proteinuric hypertension and perinatal mortality in patients with mild midtrimester hypertension. 10th World Congress of the International Society for the Study of Hypertension in Pregnancy;1996 August 4-8; Seattle, Washington, USA. 1996:131. 3035238
235. Steyn DW, Odendaal HJ. Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia. Lancet 1997;350:1267-71. 3035239
236. Steyn DW, Odendaal HJ. The effect of oral ketanserin on fetal heart rate parameters. Journal of Maternal Fetal Investigation 1998;8:126-9. 3035240
237. Steyn DW, Odendaal HJ, Kirsten GF. Mental development in children six years after in utero exposure to ketanserin - a follow-up study of a randomized controlled trial. Hypertension in Pregnancy 2002;21(Suppl 1):131. 3035232
238. Warren J, Lacoursiere Y, Varner M, Silver R, Anthony J, Belfort M. First interim report on the Labetalol versus Magnesium Sulfate for the prevention of Eclampsia Trial (LAMPET). Hypertension in Pregnancy 2004;23(Suppl 1):9. 9246126
239. Cluver CA, Walker SP, Mol BW, Theron GB, Hall DR, Hiscock R, et al. Double blind, randomised, placebo-controlled trial to evaluate the efficacy of esomeprazole to treat early onset pre-eclampsia (PIE Trial): a study protocol. BMJ Open 2015;5(10):e008211. 9246128
240. Cluver C, PACTR201608001752102 . Pre-eclampsia Intervention 2 (PI2) trial: a double blind randomised control trial of metformin for the treatment of early onset pre-eclampsia. http://www.pactr.org/ATMWeb/appmanager/atm/atmregistry?dar=true&tNo=PACTR201608001752102 (first received 23 August 2016). 9246130
241. Jayawardana J, Lekamge N. A comparison of nifedipine with methyldopa in pregnancy induced hypertension. Ceylon Medical Journal 1994;39:87-90. 3035244
242. Montan S, Ingemarsson I, Marsál K, Sjöberg NO. Negative influence of atenolol compared with pindolol on fetal hemodynamics in pregnancies with hypertension - a controlled study. Proceedings of 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:192. 3035246
243. Montan S, Ingemarsson I, Marsál K, Sjöberg NO. Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics. BMJ 1992;304:946-9. 3035247
244. Hjertberg R, Belfrage P, Faxelius G, Lagercrantz H. Neonatal outcome in infants <1500g, a randomized study of labetalol vs dihydralazine-treated hypertensive pregnant women. Proceedings of the 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:361. 3035249
245. Hjertberg R, Faxelius G, Belfrage P. Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants. Acta Obstetricia et Gynecologica Scandinavica 1993;72:611-5. 3035250
246. Hjertberg R, Faxelius G, Lagercrantz H. Neonatal adaptation in hypertensive pregnancy - a study of labetalol vs hydralazine treatment. Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland. 1994:18. 3035251
247. Hjertberg R, Faxelius G, Lagercrantz H. Neonatal adaption in hypertensive pregnancy - a study of labetalol vs hydralazine treatment. Journal of Perinatal Medicine 1993;21:69-75. 3035252
248. Lule J. Aspirin and methyldopa for moderate hypertension in pregnancy. Personal communication June 6 1992. 3035254
249. Redman CW. A controlled trial of the treatment of hypertension in pregnancy: labetalol compared with methyldopa. The investigation of labetalol in the management of hypertension in pregnancy. International Congress Series 591. Amsterdam: Excerpta Medica, 1978:101-10. 3035256
250. Redman CW. Controlled trials of treatment of hypertension during pregnancy. Proceedings of the 8th International Congress of Nephrology; 1981; Athens, Greece. 1981:523-4. 3035257
251. Harper A, Murnaghan GA. Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol. British Journal of Obstetrics and Gynaecology 1991;98:453-9. 3035260
252. Harper A, Murnaghan GA, Erskine L, Ritchie JK. Response of fetal umbilical artery time velocity waveforms to antihypertensive drugs. Proceedings of the 24th British Congress of Obstetrics and Gynaecology;1986 April 15-18; Cardiff, UK. 1986:33. 3035259
253. EUCTR2016-005206-19-BE . Randomised controlled trial with pravastatin versus placebo for prevention of preeclampsia - STATIN. http://apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-005206-19-BE (first received 7 June 2017). 9246132
254. Poon L, ISRCTN17787139 . Randomised controlled trial with pravastatin versus placebo for prevention of preeclampsia. isrctn.com/ISRCTN17787139 (first received 11 November 2015). 9246133
255. Landesman R, McLarn WD, Ollstein RN, Mendelsohn B. Reserpine in toxemia of pregnancy. Obstetrics & Gynecology 1957;9:377-83. 3035262
256. Welt SI, Dorminy JH, Jelovsek FR, Crenshaw MC, Gall SA. The effect of prophylactic management and therapeutics on hypertensive disease in pregnancy: preliminary studies. Obstetrics & Gynecology 1981;57:557-65. 3035264
257. Weiner CP. Trial to evaluate oral hypotensive agents in early onset preeclampsia. Personal communication November 1990. 9246135
258. Thaler I, Wiener Z, Manor D, Itskovitz J. Effect of calcium channel blocker nifedipine on uterine artery flow velocity waveforms. Journal of Ultrasound in Medicine 1991;10(6):301-4. 3035268
259. August P. Treatment targets for chronic hypertension in pregnancy. http://clinicaltrials.gov/ct2/show/record/NCT00194974 (accessed 17 May 2013) 2005. 3035270
260. Hameed HB, NCT00329511 . A comparison of compliance between clonidine patch and methyldopa for the treatment of chronic hypertension in pregnancy. clinicaltrials.gov/show/NCT00329511 (first received 22 May 2006). 9246137
261. Caritis S. Pravastatin for the prevention of preeclampsia in high-risk women. clinicaltrials.gov/ct2/show/NCT01717586 (first received 3 January 2012). 9246139
262. Costantine MM, Cleary K, Hebert MF, Ahmed MS, Brown LM, Ren Z, et al. Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial. American Journal of Obstetrics and Gynecology 2016;214(6):720.e1-720.e17. 9246140
263. Sánchez S, Zschaeck D, Alfonso C, González I, Kalbakdij B. Labetalol in the treatment of hypertension associated with pregnancy [Labetalol en el tratamiento de la hipertensión arterial asociada al embarazo]. Centro Médico 1985;24(81):101-9. 3035272
264. González JC, Andolcetti R. Labetalol vs. methyldopa in the treatment of hypertension in pregnancy [Labetalol vs metildopa en el tratamiento de la hipertensión arterial asociada con el embarazo]. Boletín Médico de Postgrado 1997;13(1):3-8. 3035274
265. Reyna-Villasmil E, Prieto-Franchi M, Guerra-Velázquez M, Torres-Montilla M. Effect of transdermal nitroglycerin on umbilical artery blood flow in preeclampsia (abstract). Journal of Perinatal Medicine 2001;29(Suppl 1):486. 3035276
266. Centeno DM, Urbina JC, De Las Salas M, Fuenmayor AJ. Effect of carvedilol in the treatment of hypertension in pregnant women. XLIV ERA-EDTA Congress; 2007 June 21-24; Barcelona, Spain. 2007:Poster no: FP078. 3035278
267. Smith G, ISRCTN45790835 . Use of a nitric oxide (ISMN) for the prevention and management of pre-eclampsia (pilot study). isrctn.com/ISRCTN45790835 (first received 29 November 2006). 9246142
268. Rezk M, PACTR201707002463243 . Methyldopa versus labetalol or no medication for treatment of chronic hypertension during pregnancy: a double blinded randomized clinical trial. pactr.org/ATMWeb/appmanager/atm/atmregistry?dar=true&tNo=PACTR201707002463243 (first received 24 July 2017). 9246144
269. Abdallah F, NCT03262961 . Use of sildenafil citrate in management of mild pre-eclampsia: a randomized controlled trial. clinicaltrials.gov/show/NCT03262961 (first received 19 August 2017). 9246146
270. Kubo M, JPRN-UMIN000024042 . A multicenter phase II trial of the efficacy and safety of tadalafil with pre-eclampsia. upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027686 (first received 15 September 2016). 9246148
271. Spaandermann M, NCT02531490 . Personalized hemodynamically guided antihypertensive treatment in pregnant women with mild to moderate hypertension: a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT02531490 (first received 5 August 2015). 9246150
272. Tita A, NCT02299414 . A pragmatic multicenter randomized clinical trial (RCT) of antihypertensive therapy for mild chronic hypertension during pregnancy: chronic hypertension and pregnancy (CHAP) project. clinicaltrials.gov/ct2/show/record/NCT02299414 (first received 28 October 2014). 9246152
273. Roberts R, NCT02782559 . Randomized controlled trial to assess efficacy of Sildenafil in addition to expectant management for the treatment of preterm preeclampsia. clinicaltrials.gov/ct2/show/NCT02782559 (first received 11 February 2016). 9246154
274. Towers CV, NCT03245970 . Use of impedance cardiography to decrease the risk of preeclampsia. https://clinicaltrials.gov/ct2/show/NCT03245970 (first received 8 August 2017). 9246156
275. Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2013;170(1):1-7.
276. Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP, et al. on behalf of the WHO Multicountry Survey on Maternaland Newborn Health Research Network. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World HealthOrganization Multicountry Survey on Maternal and Newborn Health. BJOG: an international journal of obstetrics and gynaecology 2014;121(Suppl 1):14-24.
277. American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstetrics and Gynecology 2013;122(5):1122-31.
278. Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertension 2014;4(2):105-45.
279. Churchill D, Beevers GD, Meher S, Rhodes C. Diuretics for preventing pre-eclampsia. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD004451.pub2]
280. Duley L, Henderson-Smart DJ. Reduced salt intake compared to normal dietary salt, or high intake, in pregnancy. Cochrane Database of Systematic Reviews 1999, Issue 3. [DOI: 10.1002/14651858.CD001687]
281. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD004659.pub2]
282. Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD001449.pub3]
283. Frishman W. Clinical pharmacology of the new beta-adrenergic drugs. Part 1. Pharmacodynamic and pharmacokinetic properties. American Heart Journal 1979;97:663-70.
284. Frishman WH, Huberfeld S, Okin S, Wang Y-H, Kumar A, Shareef B. Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease. Journal of Clinical Pharmacology 1995;35:541-72.
285. Gifford RW, August P, Chesley LC, Cunningham G, Ferris TF, Lindheimer MD, et al. National high blood pressure education program working group report on high blood pressure in pregnancy. American Journal of Obstetrics and Gynecology 1990;163:1691-712.
286. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
287. Hofmeyr GJ. Abdominal decompression for suspected fetal compromise/pre-eclampsia. Cochrane Database of Systematic Reviews 2012, Issue 6. [DOI: 10.1002/14651858.CD000004.pub2]
288. Ingenito AJ, Barrett JP, Procita L. A centrally mediated peripheral hypotensive effect of methyldopa. Journal of Pharmacology and Experimental Therapeutics 1970;175:593-9.
289. Isaac L. Clonidine in the central nervous system: site of mechanism of hypotensive action. Journal of Cardiovascular Pharmacology 1980;2(1):S5-S19.
290. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367(9516):1066-74.
291. Magee L, von Dadelszen P. Prevention and treatment of postpartum hypertension. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD004351.pub3]
292. Meher S, Duley L, on behalf of the Prevention of Pre-eclampsia Cochrane Review authors. Interventions for preventing pre-eclampsia and its consequences: generic protocol. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD005301]
293. Meher S, Abalos E, Carroli G. Bed rest with or without hospitalisation for hypertension during pregnancy. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD003514.pub2]
294. Gifford RW Jr, August PA, Cunningham G, Green LA, Lindhemier MD, McNellis D, et al. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. American Journal of Obstetrics and Gynecology 2000;183(Suppl 1):S1-S22.
295. NICE . Hypertension in pregnancy: The management of hypertensive disorders during pregnancy. NICE Clinical Guideline 107. Manchester, UK: National Institute for Health and Clinical Excellence, 2011:1-53.
296. Redman CWG, Roberts JM. Management of pre-eclampsia. Lancet 1993;341:1451-4.
297. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
298. Robinson BF, Dobbs RJ, Kelsey CR. Effects of nifedipine on resistance vessels, arteries and veins in man. British Journal of Clinical Pharmacology 1980;10:433-8.
299. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. American Journal of Obstetrics and Gynecology 1994;171(4):944-8.
300. Stunkard A, Wertheimer L, Redisch W. Studies on hydralazine; evidences for a peripheral site of action. Journal of Clinical Investigation 1954;33:1047-54.
301. Thornton JG, Hornbuckle J, Vail A, Spiegelhalter DJ, Levene M, GRIT study group. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet 2004;364(9433):513-20.
302. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000;355:87-92.
303. Wareing M, Myers JE, O'Hara M, Kenny LC, Warren AY, Taggart MJ, et al. Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries. American Journal of Obstetrics and Gynecology 2004;190(5):1283-90.
304. WHO . WHO recommendations for the prevention and treatment of pre-eclampsia and eclampsia. WHO recommendations for the prevention and treatment of pre-eclampsia and eclampsia. Geneva: WHO press, World Health Organization, October 2011.
305. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD002252]
306. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD002252.pub2]
307. Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD002252.pub3]